Acute myocarditis, prevalence, diagnosis and treatment in local hospital

Česká verzia

Authors: M. Belicová; J. Dvorský; Ľ. Vladár; M. Mokáň
Authors place of work: I. interná klinika Jeseniovej lekárskej fakulty UK a Martinskej fakultnej nemocnice, Martin, Slovenská republika, prednosta prof. MUDr. Marián Mokáň, DrSc.
Published in the journal: Vnitř Lék 2005; 51(5): 510-517
Category: Original Contributions

Summary

Clinical diagnosis of acute myocarditis is one of the greatest problems of contemporary cardiology, determined by wide clinical and laboratory polymorphysm of disease. Reliable, accurate diagnostic tests able to exclude or confirm diagnosis are not available yet.

Aim of the study:
Description of the prevalence, diagnosis and treatment of patients with acute myocarditis.

Patients:
From 1^st July 2002 to 30^th June 2003 12 patients (9 males) of age 24–49 years were hospitalised with the diagnosis of acute myocardidis.

Results:
8 patients had chest pain; these patients had changes on ECG. 4 patients had heart failure; these patients had changes on echocardiography. All patients had elevation of level of troponin T and 50% of them elevation of level of creatinkinase. All patients had fever.

Conclusion:
Acute myocarditis on the ECG was manifested by changes of the repolarization stage ST-T which simulated acute non Q and Q myocardial infarction or pericarditis. Echocardiography reveal localized kinetic disorders with dilated or not dilated chambers of heart.

Key words:
myocarditis – cardiomyopathy – cytokines – heart failure

Zdroje

1. Caforio AL, Mahon NJ, Mckenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001; 34(3): 199–204.

2. Campana C, Monti L, Arbustini E et al. Clinicopathological correlates can predict acute myocarditis in patients with recent- onset heart failure: preliminary data. Ital Heart J 2002; 3(3): 188–193.

3. Cappola TP, Felker GM, Kao WH et al. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002; 105(14): 1663–1668.

4. Dong R. Verapamil ameliorates the clinical pathological course of murine myocarditis. J Clin Invest 1992; 90: 2022–2030.

5. Furukawa Y, Kobuke K, Matsumori A. Role of cytokines in autoimmune myocarditis and cardiomyopathy. Autoimmune 2001; 34(3): 165–168.

6. Gregor P. Myokarditidy. Vnitř Lék 2000; 46(11): 801–807.

7. Gregor P. Význam elektrokardiografie u kardiomyopatií. Vnitř Lék 2002; 48(Suppl 1): 64–66.

8. Hill SL, Rose NR. The transition from viral to autoimmune myocarditis. Autoimmunity 2001; 34(3): 169–176.

9. Kvasnička J, Tušl Z, Ceral J et al. Pruměrované EKG v dlouhodobém sledování nemocného s fulminantnou myokarditídou. Vnitř Lék 2002; 48(Suppl 1): 213–215.

10. Maisch B, Ristic AD, Hufnagel G et al. Pathophysiology of viral myocarditis. The role of humoral immune response. Cardiovacs Pathol 2002; 11(2): 112–122.

11. Rezkalla S. Treatment of viral myocarditis with focus on captopril. Am J Cardiol 1996; 77: 634–637.

12. Sherry B. The role of interferon regulatory factors in the cardiac response to viral infection. Viral Immunol 2002; 15(1): 17–28.

13. Shiono T, Kodama M, Hanawa H et al. Suppression of myocardial inflammation using sumarin, a growth factor blocker. Circ J 2002; 66(4): 385–389.

14. Spodick DH. Myopericarditis/Perimyocarditis. In: Braunwald E. Heart disease. Philadelphia: WB Saunders 2001: 1836–1838.

15. Šochman J. Disciplína: akútna nekróza myokardu. Cor Vasa 2002; 44(10): 392–395.

16. Špinarová L, Toman J. Genetika dilatační kardiomyopatie a myopatií. Cor Vasa 2003; 45(6): 329–332.

17. Tabet JY, Lopes ME, Champagne S et al. Inflammation, cytokinines and antiinflammatory therapies in heart failure. Arch Mal Coeur Vaiss 2002; 95(3): 204–212.

18. Tedeschi A, Airaghi L, Giannini S et al. High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. J Intern Med 2002; 251(2): 169–173.

19. Wynne J. Myocarditis. In: Braunwald E. Heart disease. Philadelphia: WB Saunders 2001: 1783–1806.

20. Yoshida A, Kand T, Tanaka T et al. Interleukin – 18 reduces expression of cardiac tumor necrosis factor-alpha and atrial natriuretic peptide in a murine model of viral myocarditis. Life Sci 2002; 70(11): 1225–1234.